Clinical trials
Completed Phase 3 Hypoparathyroidism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 4 |
| Ascendis Pharma Bone Diseases A/S | 1 |
| Columbia University | 1 |
| Saint Petersburg State University, Russia | 1 |
| Visen Pharmaceuticals (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoparathyroidism | 8 |
| Endocrine System Diseases | 2 |
| Hypocalcemia | 2 |
| Parathyroid Diseases | 2 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Hypercalciuria | 1 |
| Hyperparathyroidism, Secondary | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.